Karl Beutner

Company: DermBiont

Job title: Chief Executive Officer & Co-Founder

Seminars:

Rethinking Rare Dermatology: Advancing Topical & Systemic Innovation in Gorlin Syndrome and Dystrophic EB 1:00 pm

Comparing topical and systemic strategies for treating rare dermatologic diseases Highlighting unmet systemic needs and treatment limitations in dystrophic EB Showcasing progress in managing basal cell carcinoma burden in Gorlin syndrome Sharing expanded data and previewing pipeline growth and potential acquisition newsRead more

day: Day Two PM